Inventia chlorthalidone tablets recalled for failed dissolution
Inventia Healthcare Limited's chlorthalidone 25 mg tablets (batch RISA24002, expiring 04/2027) failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could affect how well the medication works. About 13,567 bottles were distributed nationwide.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have chlorthalidone from Inventia Healthcare with batch number RISA24002
- Contact your pharmacy or doctor if you have this medication
- Do not stop taking your blood pressure medication without talking to your doctor first
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 13567 bottles
- Illnesses reported
- None reported
- Manufactured in
- Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, Kalyan, N/A, India
- Classification
- Class II
- Recall number
- D-0852-2026
In the FDA's words
- Description
- Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 Failed Dissolution Specifications Batch # RISA24002; Exp Date: 04/2027 Distribution: U.S. Nationwide Affected quantity: 13567 bottles
- Hazard
- Failed Dissolution Specifications